Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., Senturk O., Akyuz F., Cekic C., ...More

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.33, no.5, pp.406-413, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 5
  • Publication Date: 2022
  • Doi Number: 10.5152/tjg.2022.21868
  • Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.406-413
  • Keywords: Anti-TNF, Crohn's disease, quality of life, work productivity, ACTIVITY IMPAIRMENT QUESTIONNAIRE, INFLAMMATORY-BOWEL-DISEASE, CERTOLIZUMAB PEGOL, MAINTENANCE, ADALIMUMAB, TRIAL, INFLIXIMAB, REMISSION, MODERATE, OUTCOMES
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Background: Patients with Crohn's disease experience major deterioration in work productivity and quality of life. We aimed to provide the long-term effects of anti-tumor necrosis factor agents on work productivity and activity impairment and quality of life in patients with Crohn's disease using the Inflammatory Bowel Disease Questionnaire and the Short-Form Health Survey-36.